NASDAQ:DMRA Damora Therapeutics, Inc. Common Stock Q1 2025 Earnings Results & Report $24.46 +0.31 (+1.28%) As of 02:03 PM Eastern Damora Therapeutics, Inc. Common Stock reported Q1 2025 earnings on May 8, 2025. The company reported EPS of -$1.92. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 8, 2025TimeAfter Market ClosesConference Call DateMay 7, 2025Conference Call6:00 PM ET Damora Therapeutics, Inc. Common Stock EPS ResultsActual EPS-$1.92Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersDamora Therapeutics, Inc. Common Stock Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Damora Therapeutics, Inc. Common Stock Q1 2025 Earnings FAQ Did Damora Therapeutics, Inc. Common Stock beat earnings estimates for Q1 2025? Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) reported earnings of -$1.92 per share for Q1 2025. The report was announced on Thursday, May 8, 2025. Damora Therapeutics, Inc. Common Stock Earnings HeadlinesWhat is HC Wainwright's Estimate for DMRA FY2026 Earnings?November 9 at 1:29 AM | americanbankingnews.comGuggenheim Initiates Coverage on Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA)November 8 at 3:54 AM | americanbankingnews.comTo Washington, you're rich nowWashington just won on a promise to tax the rich. But the largest untaxed pool of money in America isn't on a yacht, it's in 401(k)s and IRAs. With a $2 trillion deficit, a new Congress could change contribution limits, timing rules, or what counts as too much, without ever raising your tax rate. Bishop Gold Group's free 2026 Gold IRA Guide shows what you can hold in your own name, under the same tax treatment you have today.November 11 at 1:00 AM | Bishop Gold Group (Ad)Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Stock Crosses Above Fifty Day Moving Average After Analyst DowngradeNovember 8 at 2:01 AM | americanbankingnews.comDamora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Stock Bumped Up to "Hold" by Wall Street ZenNovember 8 at 1:07 AM | americanbankingnews.comDamora Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 5, 2026 | marketscreener.comMSee More Damora Therapeutics, Inc. Common Stock Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Damora Therapeutics, Inc. Common Stock? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Damora Therapeutics, Inc. Common Stock and other key companies, straight to your email. Email Address About Damora Therapeutics, Inc. Common StockGalecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.View Damora Therapeutics, Inc. Common Stock ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Can Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandThe Trade Desk Beats on Revenue, But the Fine Print MattersWhy Kinder Morgan's Chairman Just Bought $15 Million in StockA $4 Billion Jolt: NRG Energy Powers Data Center Ambitions Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
